Statement Of Financial Position [Abstract]

Mithra Pharmaceuticals S.A. - Filing #3183076

Concept	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	40,717,000 EUR	—	—	—	—	38,354,000 EUR	—	—	—	—	—	—	—	—	—
Right-of-use assets	65,534,000 EUR	—	—	—	—	69,322,000 EUR	—	—	—	—	—	—	—	—	—
Goodwill	5 233 EUR	—	—	—	—	5 233 EUR	—	—	—	—	—	—	—	—	—
Intangible assets other than goodwill	134,905,000 EUR	—	—	—	—	104,954,000 EUR	—	—	—	—	—	—	—	—	—
Deferred tax assets	16,354,000 EUR	—	—	—	—	63,456,000 EUR	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	28,285,000 EUR	—	—	—	—	32,872,000 EUR	—	—	—	—	138,675,000 EUR	—	—	—	—
Assets	442 414 EUR	—	—	—	—	421 918 EUR	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	41,228,000 EUR	—	—	—	—	32,250,000 EUR	—	—	—	—	—	—	—	—	—
Retained earnings	396 254 EUR	—	—	—	—	336 633 EUR	—	—	—	—	—	—	—	—	—
Other reserves	19 934 EUR	—	—	—	—	2 545 EUR	—	—	—	—	—	—	—	—	—
Equity	33 687 EUR	396 254 EUR	41 228 EUR	19 934 EUR	408 647 EUR	33 840 EUR	336 633 EUR	2 545 EUR	340 769 EUR	32 250 EUR	157 737 EUR	31 271 EUR	219 759 EUR	13 690 EUR	332 535 EUR
Liabilities [abstract]
Deferred tax liabilities	4 420 EUR	—	—	—	—	6 089 EUR	—	—	—	—	—	—	—	—	—
Equity and liabilities	442 414 EUR	—	—	—	—	421 918 EUR	—	—	—	—	—	—	—	—	—